Conjugation to antifibrin Fab' enhances fibrinolytic potency of single-chain urokinase plasminogen activator

Circulation. 1990 Jun;81(6):1974-80. doi: 10.1161/01.cir.81.6.1974.

Abstract

Single-chain urokinase plasminogen activator (scu-PA) that had been modified with N-succinimidyl-3-(2-pyridyldithio)propionate was covalently linked by disulfide bonds to the Fab' of a monoclonal antibody specific for the beta-chain of fibrin (antibody 59D8). scu-PA-59D8 Fab' conjugate was separated from free scu-PA and two-chain urokinase coupled to 59D8 Fab' by two-step affinity chromatography. First, the reaction mixture was chromatographed on a column containing Sepharose linked to the peptide that had been used as immunogen for antibody 59D8; scu-PA-59D8 Fab' conjugate and unconjugated 59D8 Fab' were retained but not unconjugated scu-PA. Then, the eluate from the peptide-Sepharose column was chromatographed on a column containing Sepharose linked to benzamidine, which acts as a ligand for two-chain urokinase. The molecular weight of the scu-PA-59D8 Fab' conjugate was approximately 100 kDa when electrophoresed on a nonreducing sodium dodecylsulfate-polyacrylamide gel. Enzymatic assay after purification revealed that more than 97% of the scu-PA present in the conjugate retained the single-chain form. The Fab' portion of the conjugate functioned in a manner indistinguishable from that of native antibody 59D8. In an in vitro assay for lysis of fibrin monomer, the fibrinolytic potency of scu-PA-59D8 Fab' was 33-fold more than that of tissue plasminogen activator (p less than 0.001), 230-fold more than that of unconjugated scu-PA (p less than 0.0001), and 420-fold more than that of urokinase (p less than 0.0001).(ABSTRACT TRUNCATED AT 250 WORDS)

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Antibodies, Monoclonal / pharmacology*
  • Chromatography, Affinity
  • Electrophoresis, Polyacrylamide Gel
  • Fibrin / pharmacology
  • Fibrinogen / metabolism
  • Fibrinolytic Agents / chemical synthesis*
  • Molecular Weight
  • Plasminogen Activators / pharmacology*
  • Rabbits
  • Succinimides / pharmacology*
  • Tissue Plasminogen Activator / pharmacology
  • Urokinase-Type Plasminogen Activator / pharmacology*

Substances

  • Antibodies, Monoclonal
  • Fibrinolytic Agents
  • Succinimides
  • N-succinimidyl 3-(2-pyridyldithio)propionate
  • Fibrin
  • Fibrinogen
  • Plasminogen Activators
  • Tissue Plasminogen Activator
  • Urokinase-Type Plasminogen Activator